Healthcare Professional Identified Priorities for a New Musculoskeletal Examination Scoring System for People With Hemophilia—an International Consensus
INTRODUCTION: The accurate physical examination of musculoskeletal (MSK) health is an essential part of proactive best practice care of people with hemophilia and must be consistently monitored in clinic. In response to current MSK tool limitations, the Musculoskeletal Health Expert Working Group (MSKH EWG) of the International Prophylaxis Study Group (IPSG) has identified developing an improved MSK scoring system a priority. AIM: To identify the priority needs for healthcare professionals examining the MSK health of people with hemophilia in clinic. METHODS: Priorities were identified through a modified Delphi consensus process and an expert meeting with the members of the MSKH EWG. Three iterative surveys were distributed worldwide to healthcare professionals who were participants of the World Federation of Haemophilia (WFH) MSK Committee meetings. RESULTS: The modified Delphi process identified priorities of these healthcare professionals (n = 78) through surveys and an expert meeting (n = 13). The three surveys achieved response rates of 58%, 54% and 55%. The top two priorities, as to why a new MSK scoring system should be developed, were 1) current tools cannot detect the earliest and subtle changes of hemophilia, and 2) current tools are too time consuming. The top two attributes and purposes of a new MSK scoring system were to 1) measure the earliest changes of hemophilia, and 2) measure joint health changes over the course of time. CONCLUSION: The Delphi process successfully identified which future MSK examination priorities should be considered in the development of an improved MSK scoring system for clinical use.
Authors
- B. M. Feldman
- Beth Boulden Warren (ORCID: https://orcid.org/0000-0003-4416-3031)
- Magnus Aspdahl (ORCID: https://orcid.org/0000-0002-4427-5159)
- Pamela Hilliard (ORCID: https://orcid.org/0000-0002-3123-3400)
- N. Zourikian
- Lizabeth Teshler
- Melanie Bladen (ORCID: https://orcid.org/0000-0002-7413-1906)
- Audrey Abad (ORCID: https://orcid.org/0000-0001-8396-3168)
- Janjaap van der Net (ORCID: https://orcid.org/0000-0003-2606-5104)
- Jean St‐Louis (ORCID: https://orcid.org/0000-0003-1183-533X)
- Judy Ann John (ORCID: https://orcid.org/0000-0002-2526-5246)
- Sharon Funk
- Marilyn Manco-Johnson
- Merel Timmer
- David Stephensen
- Laura Avila
- F. Virginia Wright
Institutions
- Canterbury Christ Church University (GB)
- Karolinska University Hospital (SE)
- Christian Medical College, Vellore (IN)
- University of Toronto (CA)
- Utrecht University (NL)
- Great Ormond Street Hospital for Children NHS Foundation Trust (GB)
- Hospital for Sick Children (CA)
- Holland Bloorview Kids Rehabilitation Hospital (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Karolinska Institutet (SE)
- Hôpital Maisonneuve-Rosemont (CA)
- University Medical Center Utrecht (NL)
- Innovative Research Group (Canada) (CA)
- Public Health Ontario (CA)
- Institute for Clinical Evaluative Sciences (CA)
- Wilhelmina Children's Hospital (NL)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Haemophilia
- Published
- 2026-08-27
- DOI
- https://doi.org/10.1111/hae.70368
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Sanofi
- BioMarin Pharmaceutical
- Novo Nordisk
- Hospital for Sick Children
- Swedish Orphan Biovitrum